New Insights From Chinese Medical Journal Highlight the Anticancer Efficacy of Poly ADP-Ribose Polymerase Inhibitors
Poly(ADP-ribose) polymerase (PARP) inhibitors have emerged as a groundbreaking class of anticancer agents, particularly attractive for their mechanism of action ...